AGEN (STOCKS)
Agenus Inc.
$2.970000
-0.100000 (-3.26%)
Prev close: $3.070000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Garo H. Armen
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $105.83M
- Employees
- 316
- P/E (TTM)
- -1.40
- P/B (TTM)
- -0.36
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $106.83M |
| Benefits Costs and Expenses | $146.11M |
| Cost Of Revenue | $1.14M |
| Costs And Expenses | $146.11M |
| Gross Profit | $105.69M |
| Nonoperating Income/Loss | -$19.80M |
| Operating Expenses | $166.15M |
| Depreciation and Amortization | $12.66M |
| Research and Development | $105.60M |
| Other Operating Expenses | $50.92M |
| Operating Income/Loss | -$60.46M |
| Income/Loss From Continuing Operations After Tax | -$39.28M |
| Income/Loss From Continuing Operations Before Tax | -$39.28M |
| Net Income/Loss | -$39.28M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$4.11M |
| Net Income/Loss Attributable To Parent | -$35.38M |
| Net Income/Loss Available To Common Stockholders, Basic | -$35.38M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$1.97 |
| Diluted Earnings Per Share | -$2.03 |
| Basic Average Shares | 58,667,000 |
| Diluted Average Shares | 59,639,000 |
| Assets | $233.89M |
| Current Assets | $133.95M |
| Cash | $3.50M |
| Prepaid Expenses | $885.00K |
| Other Current Assets | $129.57M |
| Noncurrent Assets | $99.94M |
| Fixed Assets | $15.99M |
| Intangible Assets | $3.12M |
| Other Non-current Assets | $80.83M |
| Liabilities | $514.76M |
| Current Liabilities | $287.13M |
| Accounts Payable | $85.29M |
| Other Current Liabilities | $201.84M |
| Noncurrent Liabilities | $227.63M |
| Long-term Debt | $34.21M |
| Other Non-current Liabilities | $193.42M |
| Equity | -$280.87M |
| Equity Attributable To Noncontrolling Interest | -$6.73M |
| Equity Attributable To Parent | -$274.14M |
| Liabilities And Equity | $233.89M |
| Net Cash Flow From Operating Activities | -$89.23M |
| Net Cash Flow From Operating Activities, Continuing | -$89.23M |
| Net Cash Flow From Investing Activities | $393.00K |
| Net Cash Flow From Investing Activities, Continuing | $393.00K |
| Net Cash Flow From Financing Activities | $45.59M |
| Net Cash Flow From Financing Activities, Continuing | $45.59M |
| Net Cash Flow | -$43.25M |
| Net Cash Flow, Continuing | -$43.25M |
| Other Comprehensive Income/Loss | -$213.00K |